Tremor
TrialsCompanies

Not investment advice.

Tremor shows what changed in public records. It never tells anyone to buy or sell. Many trial edits are harmless paperwork. Data from ClinicalTrials.gov, the SEC, and the Federal Register.

PrivacyTerms

RXRX

RECURSION PHARMACEUTICALS, INC.

Tremor tracks 4 of its cancer trials.

Company-wide warning signs

These add points to every one of this company's trials.

None right now.

Trials

  • RXRXRecursion Pharmaceuticals Inc.
    0Calm

    The Symptomatic Cerebral Cavernous Malformation Trial of REC-994

    FinishedPhase 262 patientsMain results: Jun 30, 2025
  • RXRXRecursion Pharmaceuticals Inc.
    0Calm

    REC-7735 in Participants With Solid Tumors

    Signing up patientsPhase 1/290 patientsMain results: Jan 2031
  • RXRXRecursion Pharmaceuticals Inc.
    0Calm

    A Study of REC-1245 in Participants With Unresectable, Locally Advanced, or Metastatic Cancer

    Signing up patientsPhase 1/2170 patientsMain results: Oct 30, 2028
  • RXRXRecursion Pharmaceuticals Inc.
    0Calm

    Evaluate REC-4881 in Participants With Familial Adenomatous Polyposis (FAP)

    Signing up patientsPhase 1/267 patientsMain results: Jun 2027

Key executives leaving

From the last 12 months of the company's SEC reports.

None found.

Insider trades (last 6 months)

“Insiders” are executives, board members, and big shareholders. Many of their sales are pre-planned: scheduled months ahead under a legal plan (called 10b5-1), so they usually say little. Tremor only counts sales that weren't pre-planned.

13 sales (0 not pre-planned) · 0 purchases

  • Borgeson BlakeBoard member · Nov 3, 2026Sold 40,000 sharesabout $155 thousand · pre-planned
  • Borgeson BlakeBoard member · Oct 6, 2026Sold 50,000 sharesabout $242 thousand · pre-planned
  • HERSHBERG ROBERTBoard member · Oct 6, 2026Sold 25,000 sharesabout $125 thousand · pre-planned
  • Khan NajatCEO and President · Sep 8, 2026Sold 22,408 sharesabout $79 thousand · pre-planned
  • Borgeson BlakeBoard member · Sep 1, 2026Sold 30,000 sharesabout $100 thousand · pre-planned
  • Borgeson BlakeBoard member · Aug 4, 2026

Recent SEC filings

Public companies must report important news and their finances to the SEC, the US agency that oversees the stock market.

  • Quarterly reportQuarterly report (10-Q)Nov 2, 2026
  • Shared quarterly results; An executive or board member joined or left; Shared information with investorsNews report (8-K)Nov 2, 2026
  • New shares being soldNew shares being sold (424B5)Oct 15, 2026
  • Signed a major agreement; Shared quarterly results; Shared information with investors; Other newsNews report (8-K)Oct 15, 2026
  • New shares being soldNew shares being sold (424B5)Oct 15, 2026

Money left

Coming soon: how many months of cash the company has, from its quarterly reports.
Sold 30,000 shares
about $98 thousand · pre-planned
  • Borgeson BlakeBoard member · Jul 7, 2026Sold 40,000 sharesabout $159 thousand · pre-planned
  • Bumpus NamandjeBoard member · Jun 18, 2026Sold 3,963 sharesabout $13 thousand · pre-planned
  • Gibson ChristopherBoard member · Jun 5, 2026Sold 40,000 sharesabout $145 thousand · pre-planned
  • Khan NajatCEO and President · Jun 5, 2026Sold 23,588 sharesabout $84 thousand · pre-planned
  • Bumpus NamandjeBoard member · Jun 3, 2026Sold 4,386 sharesabout $16 thousand · pre-planned
  • Borgeson BlakeBoard member · Jun 2, 2026Sold 30,000 sharesabout $110 thousand · pre-planned
  • Gibson ChristopherBoard member · May 22, 2026Sold 40,000 sharesabout $123 thousand · pre-planned
    • Signed a major agreementNews report (8-K)Sep 21, 2026
  • Quarterly reportQuarterly report (10-Q)Aug 5, 2026
  • Shared quarterly results; Shared information with investorsNews report (8-K)Aug 5, 2026
  • News reportNews report (8-K)Jun 18, 2026